• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

FCGR1A Gene Record

  • Summary
  • Interactions
  • Claims
  • FCGR1A 2209 Druggable Genome

    Alternate Names:

    2209
    FC FRAGMENT OF IGG RECEPTOR IA
    FCGR1A
    CD64
    CD64A
    FCRI
    IGFR1
    146760
    3613
    ENSG00000150337
    OTTHUMG00000012089
    FCG1
    FcgammaRIa
    FCGR1
    High affinity immunoglobulin gamma Fc receptor I
    Fc-gamma RI
    Fc-gamma RIA
    CD_antigen=CD64
    IgG Fc receptor I
    BE0000710
    P12314

    Gene Info:

    Gene Biotype PROTEIN_CODING
    (2 More Sources)

    Gene Categories: Category Details

    DRUGGABLE GENOME

    Publications:

    Simms et al., 1991, Monokines released during short-term Fc gamma receptor phagocytosis up-regulate polymorphonuclear leukocytes and monocyte-phagocytic function., J. Immunol.
    Hofmann HP et al., 2016, Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel(®))., Expert Opin Biol Ther
    Arora T et al., 2009, Differences in binding and effector functions between classes of TNF antagonists., Cytokine
    Overington et al., 2006, How many drug targets are there?, Nat Rev Drug Discov
    Imming et al., 2006, Drugs, their targets and the nature and number of drug targets., Nat Rev Drug Discov
    White AL et al., 2013, FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs., Cancer Immunol Immunother
    Dudek S et al., 2019, Human Fcγ receptors compete for TGN1412 binding that determines the antibody's effector function., Eur J Immunol
    Curnow, Clinical experience with CD64-directed immunotherapy. An overview., Cancer Immunol. Immunother.
    Wang Y et al., 2004, Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro., Angiogenesis
    Hiatt A et al., 2014, Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy., Proc Natl Acad Sci U S A
    Negri et al., 1995, In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody., Br. J. Cancer
    Hudkins RL et al., 2012, Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): a novel oncology therapeutic agent., J Med Chem
    Seimetz D et al., 2010, Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy., Cancer Treat Rev
    Nagai Y et al., 2019, Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys., Xenobiotica
    Tamura K et al., 2019, Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study., Lancet Oncol
  • TRASTUZUMAB DERUXTECAN   FCGR1A

    Interaction Score: 6.55

    Interaction Types & Directionality:
    antibody (inhibitory)

    Interaction Info:

    PMIDs:
    30351177 31047803


    Sources:
    DrugBank

  • MDX-447   FCGR1A

    Interaction Score: 6.55

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Mechanism of Interaction High affinity immunoglobulin gamma Fc receptor I other
    Direct Interaction yes

    PMIDs:
    9435876


    Sources:
    NCI ChemblInteractions

  • NATALIZUMAB   FCGR1A

    Interaction Score: 2.91

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    31002172 17139284 17016423


    Sources:
    DrugBank

  • PALIVIZUMAB   FCGR1A

    Interaction Score: 2.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423 24711420


    Sources:
    DrugBank

  • MDX-210   FCGR1A

    Interaction Score: 2.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Mechanism of Interaction High affinity immunoglobulin gamma Fc receptor I other
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • ALEMTUZUMAB   FCGR1A

    Interaction Score: 2.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    23543215 17139284 17016423


    Sources:
    DrugBank

  • CATUMAXOMAB   FCGR1A

    Interaction Score: 1.09

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:

    PMIDs:
    20347527


    Sources:
    DrugBank

  • ETANERCEPT   FCGR1A

    Interaction Score: 0.87

    Interaction Types & Directionality:
    ligand

    Interaction Info:

    PMIDs:
    27463856 19128982 17139284 17016423


    Sources:
    DrugBank

  • SARILUMAB   FCGR1A

    Interaction Score: 0.73

    Interaction Types & Directionality:
    other/unknown

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DrugBank

  • DACLIZUMAB   FCGR1A

    Interaction Score: 0.62

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    1828823


    Sources:
    DrugBank

  • CEP-11981   FCGR1A

    Interaction Score: 0.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22148921


    Sources:
    DTC

  • BEVACIZUMAB   FCGR1A

    Interaction Score: 0.43

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423 15886877


    Sources:
    DrugBank

  • CETUXIMAB   FCGR1A

    Interaction Score: 0.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    7547242


    Sources:
    DrugBank

  • Ensembl: ENSG00000150337

    • Version: 101_38

    Alternate Names:
    FCGR1A Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • DrugBank: BE0000710

    • Version: 5.1.7

    Alternate Names:
    FCGR1A DrugBank Gene Name
    P12314 UniProt Accession
    2209 Entrez Gene Id

    Gene Info:

    Publications:
    Hofmann HP et al., 2016, Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel(®))., Expert Opin Biol Ther
    Arora T et al., 2009, Differences in binding and effector functions between classes of TNF antagonists., Cytokine
    Negri et al., 1995, In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody., Br. J. Cancer

  • NCI: FCGR1A

    • Version: 14-September-2017

    Alternate Names:

    Gene Info:

    Publications:
    Curnow, Clinical experience with CD64-directed immunotherapy. An overview., Cancer Immunol. Immunother.
    Cassatella et al., 1991, Interferon-gamma transcriptionally modulates the expression of the genes for the high affinity IgG-Fc receptor and the 47-kDa cytosolic component of NADPH oxidase in human polymorphonuclear leukocytes., J. Biol. Chem.

  • DTC: FCGR1A

    • Version: 02-September-2020

    Alternate Names:

    Gene Info:

    Publications:
    Hudkins RL et al., 2012, Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): a novel oncology therapeutic agent., J Med Chem

  • HingoraniCasas: ENSG00000150337

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000150337 Gene Symbol
    FCGR1A Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • ChemblInteractions: FCG1

    • Version: chembl_23

    Alternate Names:
    FCGR1 GENE_SYMBOL
    IGFR1 GENE_SYMBOL
    FCGR1A GENE_SYMBOL

    Gene Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21